ARCHIVES

In Brief: Survivors Day Scheduled For April 30; Miami Center Names Changed; NCI’s Adamson Honored

This article is from The Cancer Letter archive.

Vol. 15 No. 15 | April 14, 1989

Download PDF Visit The Full Archive

Related Articles

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

NCCS Networker Volume 8 Issue 2, Summer 1994

June 13, 1994

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014